Ascend Advanced Therapies and ABL Inc. form a premier CDMO alliance with 50+ years of viral manufacturing expertise. We deliver high-quality, cost-effective development and commercial-scale manufacturing of AAV gene therapies, viral oncolytics, and vaccines—accelerating time-to-market for biotech innovators across multiple advanced therapy modalities.
